UK MHRA's Wilkinson questions proposed EU scrutiny mechanism for devices; Commission argues it is notified body measure
This article was originally published in SRA
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency has questioned certain measures that the European Commission has included in its Medical Device Regulation (MDR) proposal, including the proposition for establishing a pre-market scrutiny mechanism for high-risk products1-3.